COMP <GO>
INNV vs MRK // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
InnovAge Holding Corp. (NASDAQ) VS. Merck & Company Inc. (NYSE) • 15-METRIC TALLY: INNV 1
— MRK 10
■ METRIC PARITY
LAST: $9.19 (-0.54%) • MKT CAP: $1.26B
options-implied-move
—
LAST: $149.52 (+2.18%) • MKT CAP: $361.02B
options-implied-move
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (INNV VS. MRK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | INNV | MRK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 18.00% | 74.80% | -56.80 | MRK | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -10.20% | 20.70% | -30.90 | MRK | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 15.3x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 2.11% | 3.42% | -1.31 | MRK | /fcf-yield <GO> |
| Operating Margin | -3.50% | 34.30% | -37.80 | MRK | /operating-margins <GO> |
| Net Profit Margin | -3.60% | 28.10% | -31.70 | MRK | /net-margins <GO> |
| Revenue Growth (YoY) | 11.80% | 1.30% | +10.50 | INNV | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.26% | -2.26 | MRK | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.47 | 5.19 | -0.72 | MRK | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 7/9 | -1.00 | MRK | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 47.2 | 51.7 | -4.50 | MRK | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.92 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 18.4x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.26B | $361.02B | -$359.76B | MRK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | INNV REV | MRK REV | INNV GROSS % | MRK GROSS % | INNV FCF | MRK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $853.7M | $65.01B | 18.0% | 74.8% | $26.6M | $12.36B |
| FY 2024 | $763.9M | $64.17B | 17.3% | 76.3% | -$44.8M | $18.10B |
| FY 2023 | $688.1M | $60.12B | — | — | $20.2M | $10.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
INNV // BETA —
MRK // BETA 0.92